Antoinette Tan, MD, MHS
Clinical Expertise: novel targets in the treatment of breast cancer, triple-negative breast cancer, drug development
Antoinette R. Tan, MD, MHSc, is the Chief of Breast Medical Oncology and Co-Director of the Phase I Program at Levine Cancer Institute, Carolinas HealthCare System. She is Chief of Medical Oncology at Carolinas HealthCare System’s Carolinas Medical Center-Pineville location. She is also a Clinical Professor in the Department of Medicine at the University of North Carolina. She graduated from Rutgers University in 1993 with a bachelor’s degree in Biological Sciences. She received her medical degree from Rutgers-Robert Wood Johnson Medical School in 1996 through an accelerated BA/MD program. After completing her internship and residency in internal medicine at North Shore University Hospital–New York University School of Medicine and Memorial Sloan-Kettering Cancer Center, she completed an oncology fellowship at the National Cancer Institute. Dr. Tan also obtained formal training in clinical research during her fellowship and was awarded a Master of Health Sciences degree from Duke University School of Medicine.
Prior to joining Levine Cancer Institute, Dr. Tan was an Associate Professor of Medicine at Rutgers Cancer Institute of New Jersey. In 2010, she was appointed to be Director of Phase and Investigational Therapeutics at Rutgers Cancer Institute of New Jersey. Her research interests focus on targeted treatments for breast cancer and drug development. She has extensive experience in the conduct of early phase clinical trials and breast cancer studies. Dr. Tan has served on the American Society of Clinical Oncology Education Program, as Chair and as a Breast Cancer Track Leader. In 2012, she was awarded the NCI Cancer Clinical Investigator Team Leadership Award.
Antoinette Tan
Clinical Expertise: novel targets in the treatment of breast cancer, triple-negative breast cancer, drug development
Antoinette R. Tan, MD, MHSc, is the Chief of Breast Medical Oncology and Co-Director of the Phase I Program at Levine Cancer Institute, Carolinas HealthCare System. She is Chief of Medical Oncology at Carolinas HealthCare System’s Carolinas Medical Center-Pineville location. She is also a Clinical Professor in the Department of Medicine at the University of North Carolina. She graduated from Rutgers University in 1993 with a bachelor’s degree in Biological Sciences. She received her medical degree from Rutgers-Robert Wood Johnson Medical School in 1996 through an accelerated BA/MD program. After completing her internship and residency in internal medicine at North Shore University Hospital–New York University School of Medicine and Memorial Sloan-Kettering Cancer Center, she completed an oncology fellowship at the National Cancer Institute. Dr. Tan also obtained formal training in clinical research during her fellowship and was awarded a Master of Health Sciences degree from Duke University School of Medicine.
Prior to joining Levine Cancer Institute, Dr. Tan was an Associate Professor of Medicine at Rutgers Cancer Institute of New Jersey. In 2010, she was appointed to be Director of Phase and Investigational Therapeutics at Rutgers Cancer Institute of New Jersey. Her research interests focus on targeted treatments for breast cancer and drug development. She has extensive experience in the conduct of early phase clinical trials and breast cancer studies. Dr. Tan has served on the American Society of Clinical Oncology Education Program, as Chair and as a Breast Cancer Track Leader. In 2012, she was awarded the NCI Cancer Clinical Investigator Team Leadership Award.